Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Feb 01, 2021 11:14am
187 Views
Post# 32436328

RE:RE:RE:CR going up!!!

RE:RE:RE:CR going up!!!
Eoganacht wrote: That's what it looks like. The 45% CR would be the percentage of CR patients from the 9 patients who have received or will receive a 180 day assessment. If 13 and 14 are CR then we'll be at 67% CR of those patients. Things look really great going forward.

fredgoodwinson wrote: Is it correct that the 9 patients are arrived at by taking 5 withdrawn from the original 12 to leave 7 and then adding Patients 13 & 14?

If so the 2 'to be determined' will be the only ones to have received the correct full dosing so might await their outcomes with some optimism.




I'm guessing TLT will get another 10 enrolled in study 2 in Canada this qtr. By Summer another 10 in Canada and perhaps 25 in the US? So I think the CR % by fall 2022 will be 80% + as these patients approach their 15 month CR dates. :-)

<< Previous
Bullboard Posts
Next >>